Ireland - English - HPRA (Health Products Regulatory Authority)

merz pharmaceuticals gmbh - clostridium botulinum neurotoxin type a (150kd), free of complexing proteins - powder for solution for injection - 100 unit(s) - botulinum toxin

Ireland - English - HPRA (Health Products Regulatory Authority)

merz pharmaceuticals gmbh - clostridium botulinum neurotoxin type a (150kd), free of complexing proteins - powder for solution for injection - 50 unit(s) - botulinum toxin

Ireland - English - HPRA (Health Products Regulatory Authority)

croma-pharma gmbh - clostridium botulinum neurotoxin type a (900 kd) - powder for solution for injection - botulinum toxin

Singapore - English - HSA (Health Sciences Authority)

abbvie pte. ltd. - clostridium botulinum toxin type a - injection, powder, for solution - 100 units/vial - clostridium botulinum toxin type a 100 units/vial

Singapore - English - HSA (Health Sciences Authority)

abbvie pte. ltd. - clostridium botulinum toxin type a - injection, powder, for solution - 50 units - clostridium botulinum toxin type a 50 units

Ireland - English - HPRA (Health Products Regulatory Authority)

ipsen pharma - clostridium botulinum toxin type a haemagglutinin complex - powder for solution for injection - 125 speywood - other muscle relaxants, peripherally acting agents; botulinum toxin

Canada - English - Health Canada

aventis pasteur limited - botulinum antitoxin; botulinum antitoxin; botulinum antitoxin - solution - 7500unit; 5500unit; 8500unit - botulinum antitoxin 7500unit; botulinum antitoxin 5500unit; botulinum antitoxin 8500unit - serums

United States - English - NLM (National Library of Medicine)

emergent biosolutions canada inc. - equine botulinum neurotoxin a immune fab2 (unii: le3j6i6dxp) (equine botulinum neurotoxin a immune fab2 - unii:le3j6i6dxp), equine botulinum neurotoxin b immune fab2 (unii: vsk09vp4hl) (equine botulinum neurotoxin b immune fab2 - unii:vsk09vp4hl), equine botulinum neurotoxin c immune fab2 (unii: x5i2p7e9ty) (equine botulinum neurotoxin c immune fab2 - unii:x5i2p7e9ty), equine botulinum neurotoxin d immune fab2 (unii: 30y9n0sebe) (equine botulinum neurotoxin d immune fab2 - unii:30y9n0sebe), equine botul - equine botulinum neurotoxin a immune fab2 4500 [iu] in 10 ml - bat [botulism antitoxin heptavalent (a, b, c, d, e, f, g) – (equine)] is a mixture of immune globulin fragments indicated for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes a, b, c, d, e, f, or g in adults and pediatric patients. the effectiveness of bat is based on efficacy studies conducted in animal models of botulism. none. risk summary there are no human or animal data to establish the presence or absence of bat associated risk. risk summary there are no data to assess the presence or absence of bat in human milk, the effects on the breastfed child or the effects on milk production/excretion. consider the developmental and health benefits of breastfeeding along with the mother’s clinical need for bat and any potential adverse effects on the breastfed child from bat or from the underlying maternal condition. the effectiveness of bat has not been established in pediatric patients. limited pediatric safety data are available. fifteen pediat

Australia - English - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd - incobotulinumtoxina, quantity: 100 u - injection, powder for - excipient ingredients: albumin; sucrose - xeomin is indicated in adults for the treatment of:,? cervical dystonia (spasmodic torticollis),? blepharospasm,? spasticity of the upper limb,? chronic sialorrhea due to neurological disorders,? upper facial lines,- glabellar frown lines,- lateral periorbital lines (crow?s feet),- horizontal forehead lines,xeomin is indicated in children and adolescents aged 2 years to 17 years for the symptomatic treatment of:,? chronic sialorrhea due to neurological/neurodevelopmental disorders,? spasticity of the lower and/or upper limbs

Australia - English - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd - incobotulinumtoxina, quantity: 50 u - injection, powder for - excipient ingredients: albumin; sucrose - xeomin is indicated in adults for the treatment of:,? cervical dystonia (spasmodic torticollis),? blepharospasm,? spasticity of the upper limb,? chronic sialorrhea due to neurological disorders,? upper facial lines,- glabellar frown lines,- lateral periorbital lines (crow?s feet),- horizontal forehead lines,xeomin is indicated in children and adolescents aged 2 years to 17 years for the symptomatic treatment of:,? chronic sialorrhea due to neurological/neurodevelopmental disorders,? spasticity of the lower and/or upper limbs